{"altmetric_id":21262892,"counts":{"readers":{"mendeley":4,"citeulike":0,"connotea":0},"total":{"posts_count":8},"twitter":{"unique_users_count":7,"unique_users":["ProfOculista","DrBridgitte","profluigimarino","BirthTissueBTR","leahfunk","AdrianMollo","CO_Ophthalmo"],"posts_count":8}},"selected_quotes":["Amniotic membrane use for management of corneal limbal stem cell deficiency. Cred: @CO_Ophthalmo #placentadonation","@profluigimarino @Eyeppl @HelpMyDryEyes @Dryeyemaster @pismoeyedoc @ClarkChangOD @MMarkoulli @dryeyecoach @Eyedolatry_Blog\u2026","@profluigimarino #dryeye #ocularsurface disease #stemcell #amnioticmembrane #regenerativemedicine #Ophthalmology #optometry #SoMe"],"citation":{"abstract":"The current article reviews the most recent surgical techniques for management of corneal limbal stem cell deficiency (LSCD) using amniotic membrane tissue.\nEarly successes with amniotic membrane transplantation (AMT) for the treatment of ocular surface disorders have encouraged clinicians to investigate new applications. The use of AMT as a temporary patch in emergency cases in which LSCD may develop has considerably improved the prognosis of these patients. Amniotic membrane does not have stem cells of its own, but it supports regeneration of limbal epithelial stem cells (LESCs). Similarly, the combination of AMT with classic surgical techniques has enhanced the surgical success rates in most case series. Furthermore, based on its advantageous properties as a cell carrier, new applications to support in-vivo and ex-vivo cell expansion have been reported recently.\nLSCD constitutes a general indication for AMT. Based on the clinical scenario, AMT may be performed alone to support regeneration of LESCs, in combination with other surgical techniques, or even supporting the in-vivo or ex-vivo expansion of LESCs.","altmetric_jid":"4f6fa5e63cf058f610005866","authors":["Sabater, Alfonso L.","Perez, Victor L."],"doi":"10.1097\/icu.0000000000000386","first_seen_on":"2017-06-22T11:00:39+00:00","issns":["1040-8738"],"issue":"4","journal":"Current opinion in ophthalmology","last_mentioned_on":1503401443,"links":["http:\/\/journals.lww.com\/co-ophthalmology\/Abstract\/2017\/07000\/Amniotic_membrane_use_for_management_of_corneal.12.aspx"],"pdf_url":"http:\/\/pdfs.journals.lww.com\/co-ophthalmology\/2017\/07000\/Amniotic_membrane_use_for_management_of_corneal.12.pdf","pmid":"28426442","pubdate":"2017-07-01T00:00:00+00:00","publisher":"LWW","publisher_subjects":[{"name":"Ophthalmology And Optometry","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"363\u2013369","subjects":["ophthalmology"],"title":"Amniotic membrane use for management of corneal limbal stem cell deficiency","type":"article","uri":"http:\/\/journals.lww.com\/co-ophthalmology\/Fulltext\/2017\/07000\/Amniotic_membrane_use_for_management_of_corneal.12.aspx","volume":"28","mendeley_url":"http:\/\/www.mendeley.com\/research\/amniotic-membrane-management-corneal-limbal-stem-cell-deficiency"},"altmetric_score":{"score":4.95,"score_history":{"1y":4.95,"6m":4.95,"3m":4.7,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":4.95},"context_for_score":{"all":{"total_number_of_other_articles":8414405,"mean":7.0824487780638,"rank":1713687,"this_scored_higher_than_pct":79,"this_scored_higher_than":6694340,"rank_type":"exact","sample_size":8414405,"percentile":79},"similar_age_3m":{"total_number_of_other_articles":237298,"mean":12.957706249973,"rank":62389,"this_scored_higher_than_pct":73,"this_scored_higher_than":174550,"rank_type":"exact","sample_size":237298,"percentile":73},"this_journal":{"total_number_of_other_articles":569,"mean":2.5233063380282,"rank":42,"this_scored_higher_than_pct":92,"this_scored_higher_than":527,"rank_type":"exact","sample_size":569,"percentile":92},"similar_age_this_journal_3m":{"total_number_of_other_articles":26,"mean":0.668,"rank":1,"this_scored_higher_than_pct":96,"this_scored_higher_than":25,"rank_type":"exact","sample_size":26,"percentile":96}}},"demographics":{"poster_types":{"member_of_the_public":7},"users":{"twitter":{"cohorts":{"Members of the public":7}},"mendeley":{"by_status":{"Unspecified":1,"Student  > Postgraduate":1,"Professor":1,"Student  > Master":1},"by_discipline":{"Medicine and Dentistry":2,"Materials Science":1,"Unspecified":1}}},"geo":{"twitter":{"US":3,"IT":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/ProfOculista\/statuses\/877843702340698112","license":"gnip","citation_ids":[21262892],"posted_on":"2017-06-22T11:00:22+00:00","author":{"name":"Professione Oculista","image":"https:\/\/pbs.twimg.com\/profile_images\/536891307445088256\/tV4xeFVM_normal.png","description":"#AggiornamentoProfessionale per Medici #Oculisti.\nCorso #ECM #ProfessioneOculista accreditato dal #MinisteroDellaSalute 36 crediti in modalit\u00e0 #FAD.","id_on_source":"ProfOculista","tweeter_id":"2396396083","geo":{"lt":null,"ln":null},"followers":386},"tweet_id":"877843702340698112"},{"url":"http:\/\/twitter.com\/DrBridgitte\/statuses\/879386879828873216","license":"gnip","rt":["ProfOculista"],"citation_ids":[21262892],"posted_on":"2017-06-26T17:12:25+00:00","author":{"name":"Bridgitte Shen Lee","url":"https:\/\/www.instagram.com\/drbridgitte\/","image":"https:\/\/pbs.twimg.com\/profile_images\/801221962181787648\/V36GjOE9_normal.jpg","description":"Optometrist & CEO @visionoptique @OptometryCE #iTravelCE || Educator #DigitalEyeHealth\u00ae #AntiAgingEyecare #OcularAesthetics\u2120 #optometry","id_on_source":"DrBridgitte","tweeter_id":"145074366","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":2484},"tweet_id":"879386879828873216"},{"url":"http:\/\/twitter.com\/DrBridgitte\/statuses\/879387975314010112","license":"gnip","citation_ids":[21262892],"posted_on":"2017-06-26T17:16:46+00:00","author":{"name":"Bridgitte Shen Lee","url":"https:\/\/www.instagram.com\/drbridgitte\/","image":"https:\/\/pbs.twimg.com\/profile_images\/801221962181787648\/V36GjOE9_normal.jpg","description":"Optometrist & CEO @visionoptique @OptometryCE #iTravelCE || Educator #DigitalEyeHealth\u00ae #AntiAgingEyecare #OcularAesthetics\u2120 #optometry","id_on_source":"DrBridgitte","tweeter_id":"145074366","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":2484},"tweet_id":"879387975314010112"},{"url":"http:\/\/twitter.com\/profluigimarino\/statuses\/879396685616738304","license":"gnip","rt":["DrBridgitte"],"citation_ids":[21262892],"posted_on":"2017-06-26T17:51:22+00:00","author":{"name":"luigi marino","url":"http:\/\/www.luigimarino.com","image":"https:\/\/pbs.twimg.com\/profile_images\/3348393826\/7a6d9e4146a3a5ff93be48c1abb437e0_normal.jpeg","description":"Pediatric & Adult Eye Care, Refractive Laser, Femtolasik, Femtolaser Cataract, Macula Research , Dry Eye specialist","id_on_source":"profluigimarino","tweeter_id":"1043099688","geo":{"lt":45.46427,"ln":9.18951,"country":"IT"},"followers":1576},"tweet_id":"879396685616738304"},{"url":"http:\/\/twitter.com\/BirthTissueBTR\/statuses\/880038152613875712","license":"gnip","citation_ids":[21262892],"posted_on":"2017-06-28T12:20:20+00:00","author":{"name":"BirthTissueRecovery","url":"http:\/\/www.birthtissuerecovery.com","image":"https:\/\/pbs.twimg.com\/profile_images\/709416014119706625\/oGI1LhgD_normal.jpg","description":"BTR is a FDA-registered and AATB-accredited tissue bank dedicated to the acquisition of human birth tissue suitable for transplant and allograft manufacturing.","id_on_source":"BirthTissueBTR","tweeter_id":"4054951996","geo":{"lt":36.09986,"ln":-80.24422,"country":"US"},"followers":59},"tweet_id":"880038152613875712"},{"url":"http:\/\/twitter.com\/leahfunk\/statuses\/880220567042916353","license":"gnip","rt":["BirthTissueBTR"],"citation_ids":[21262892],"posted_on":"2017-06-29T00:25:11+00:00","author":{"name":"Leah Weber","image":"https:\/\/pbs.twimg.com\/profile_images\/519984880160354304\/Hbhs9IWZ_normal.jpeg","id_on_source":"leahfunk","tweeter_id":"123557542","geo":{"lt":null,"ln":null},"followers":17},"tweet_id":"880220567042916353"},{"url":"http:\/\/twitter.com\/AdrianMollo\/statuses\/880246104486547459","license":"gnip","rt":["BirthTissueBTR"],"citation_ids":[21262892],"posted_on":"2017-06-29T02:06:40+00:00","author":{"name":"Adrian Mollo","image":"https:\/\/pbs.twimg.com\/profile_images\/2513119484\/image_normal.jpg","description":"General counsel for regenerative medicine company, IP lawyer, and deal maker; fan of disruptive technologies, sci-fi, and beer.","id_on_source":"AdrianMollo","tweeter_id":"629028405","geo":{"lt":39.24038,"ln":-76.83942,"country":"US"},"followers":32},"tweet_id":"880246104486547459"},{"url":"http:\/\/twitter.com\/CO_Ophthalmo\/statuses\/899956998422253568","license":"gnip","citation_ids":[21262892],"posted_on":"2017-08-22T11:30:43+00:00","author":{"name":"CO Ophthalmology","url":"http:\/\/www.co-ophthalmology.com","image":"https:\/\/pbs.twimg.com\/profile_images\/1706251956\/ICU_square_cover_normal.jpg","description":"Provides powerful perspectives on the most important advances in published literature, delivering expert assessments of developments from the previous year.","id_on_source":"CO_Ophthalmo","tweeter_id":"368321542","geo":{"lt":null,"ln":null},"followers":362},"tweet_id":"899956998422253568"}]}}